Doctor Sayaka Funabashi

Doctor Sayaka Funabashi

Kyorin University, Tokyo (Japan)

Member of:

2005-2011 Kyorin University, Tokyo, Japan 2011-2013 Internship, Kyorin University Hospital, Tokyo, Japan 2013-2016 Cardiology Resident, Kyorin University Hospital, Tokyo, Japan 2016-2019 Cardiology Resident, Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center, Osaka, Japan 2019-2021 Cardiology Fellow, Department of Cardiovascular Medicine National Cerebral and Cardiovascular Center, Osaka, Japan 2021-2022 Cardiology Clinical Fellow, Kyorin University Hospital, Tokyo, Japan 2022- Cardiology Assistant Professor, Kyorin University Hospital, Tokyo, Japan

Presentations

Apolipoprotein B and the regression of lipidic plaque in statin-treated type 2 DM patients with coronary artery disease: the pre-specified sub-analysis from the OPTIMAL randomized controlled trial

Event: ESC Congress 2024

Topic: Lipids

Session: Lipids as risk factors for cardiovascular disease

Access

The effect of achieving LDL-C <1.8 mmol/L to prevent the first atherosclerotic cardiovascular events in the primary prevention settings of severe heterozygous familial hypercholesterolemia

Event: ESC Congress 2022

Topic: Lipids

Session: Optimal risk factor therapy in high risk patients

Access

Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease

Event: ESC Congress 2021 - The Digital Experience

Topic: Pathophysiology

Session: Risk Factors and Prevention ePosters

Access

Lp (a) > 50 mg/dl predicts atherosclerotic cardiovascular events in patients with heterozygous familial hypercholesterolemia who achieved LDL-C < 2.6 mmol/l

Event: ESC Congress 2020

Topic: Lipids

Session: Risk Factors and Prevention ePosters

Access

Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Peripheral Vascular and Cerebrovascular Disease ePosters

Access

Extensive formation of atherosclerotic cardiovascular disease in subjects with severe familial hypercholesterolemia defined by the international atherosclerosis society criteria

Event: ESC Congress 2019

Topic: Clinical

Session: Comorbidities and prognosis in peripheral artery disease

Access

Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure

Event: ESC Congress 2018

Topic: Biomarkers

Session: Best Posters in acute heart failure

Access

ESC 365 is supported by

Explore sponsored resources

Doctor Sayaka Funabashi

Biography

Contributor content

Apolipoprotein B and the regression of lipidic plaque in statin-treated type 2 DM patients with coronary artery disease: the pre-specified sub-analysis from the OPTIMAL randomized controlled trial

The effect of achieving LDL-C <1.8 mmol/L to prevent the first atherosclerotic cardiovascular events in the primary prevention settings of severe heterozygous familial hypercholesterolemia

Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease

Lp (a) > 50 mg/dl predicts atherosclerotic cardiovascular events in patients with heterozygous familial hypercholesterolemia who achieved LDL-C < 2.6 mmol/l

Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis

Extensive formation of atherosclerotic cardiovascular disease in subjects with severe familial hypercholesterolemia defined by the international atherosclerosis society criteria

Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure

ESC 365 is supported by

Doctor Sayaka Funabashi Follow

Biography

Contributor content

Apolipoprotein B and the regression of lipidic plaque in statin-treated type 2 DM patients with coronary artery disease: the pre-specified sub-analysis from the OPTIMAL randomized controlled trial

The effect of achieving LDL-C <1.8 mmol/L to prevent the first atherosclerotic cardiovascular events in the primary prevention settings of severe heterozygous familial hypercholesterolemia

Characterization of cholesterol efflux capacity in diabetic and non-diabetic patients with coronary artery disease: comparison between acute coronary syndrome and stable coronary artery disease

Lp (a) > 50 mg/dl predicts atherosclerotic cardiovascular events in patients with heterozygous familial hypercholesterolemia who achieved LDL-C < 2.6 mmol/l

Prevalence, clinical characteristics and prognosis of intracranial artery atherosclerosis in heterozygous familial hypercholesterolemia: insights from magnetic resonance angiography imaging analysis

Extensive formation of atherosclerotic cardiovascular disease in subjects with severe familial hypercholesterolemia defined by the international atherosclerosis society criteria

Long-term prognostic significance of renal tubular damage, as assessed by urinary Nacetyl-beta-D-glucosamidase, on admission in patients with acute heart failure

ESC 365 is supported by

Doctor Sayaka Funabashi